Chao Kong

Paclitaxel and Itraconazole Co‐Encapsulated Micelle Prolongs the Survival of Spontaneous LSL‐KrasG12D/+, LSL‐Trp53R172H/+, Pdx‐1‐Cre Genetically Engineered Mouse Model of Pancreatic Cancer

F. Qian, Z. Tian, Fang Yuan, 2019, Advanced Therapeutics.

Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma.

Rui Wang, Jie Ma, Huiqin Liu, 2022, Cancer letters.

Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release.

Jinming Gao, Zhaohui Wang, Yang Li, 2019, ACS nano.

KRAS‐enhanced macropinocytosis and reduced FcRn‐mediated recycling sensitize pancreatic cancer to albumin‐conjugated drugs

David C. S. Huang, Junxiao Ye, F. Qian, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization.

F. Qian, Junhao Zhu, Chao Kong, 2015, International journal of pharmaceutics.

Improving Drug Delivery of Micellar Paclitaxel against Non-Small Cell Lung Cancer by Coloading Itraconazole as a Micelle Stabilizer and a Tumor Vascular Manipulator.

Huijun Chen, F. Qian, Kuan Yang, 2018, Small.

Tumor Progression of Non-Small Cell Lung Cancer Controlled by Albumin and Micellar Nanoparticles of Itraconazole, a Multitarget Angiogenesis Inhibitor.

Huijun Chen, F. Qian, Kuan Yang, 2017, Molecular pharmaceutics.

Schiff base interaction tuned mesoporous organosilica nanoplatforms with pH-responsive degradability for efficient anti-cancer drug delivery in vivo.

Tian Zhao, Yen Wei, Chengyu Liu, 2018, Chemical communications.